Professional Whistleblowers, Medical Necessity and Compliance Implications: Laboratory Learnings from MD Lab’s Qui Tam Victory

Proving medical necessity for diagnostic testing remains one of the most heavily scrutinized and labor-intensive areas in laboratory billing compliance. Payer audits, appeals of payment denials, medical records requests, pre- and post- payment reviews, recoupment demands, whistleblower actions, and False Claims Act investigations continue to create significant financial and operational risk for laboratories across the country.

In a recent landmark case, MD Labs successfully defended itself against allegations that it knowingly billed for medically-unnecessary PCR testing. The decision has drawn national attention because of its potential implications for how courts evaluate physician orders, laboratory responsibility, and the evidence required to establish False Claims Act liability.

Join us at 2 p.m. EDT, Wednesday, July 22, for an in-depth discussion with Matthew Rutledge, Owner of MD Labs, and Danielle Tangorre, Partner at Robinson+Cole and lead counsel for MD Labs in the litigation. Together, they will examine the case from both the laboratory and legal perspectives, exploring what laboratory leaders should understand moving forward.

This session will focus on practical lessons for laboratories navigating today's increasingly complex compliance environment. Attendees will gain insight into how medical necessity challenges arise, how laboratories should prepare for and respond to audits and investigations, what resources are available when issues emerge, and why documented compliance programs remain essential even in light of this favorable ruling.

Topics will include:
• The evolving relationship between physician orders, laboratory testing, and medical necessity
• What laboratories should know about audits, payer reviews, clawbacks, and False Claims Act investigations
• Key takeaways from the MD Labs case and the precedent it may establish
• Practical considerations when responding to allegations of medically unnecessary testing
• Compliance, risk management, and documentation strategies for today's laboratory environment

This session is designed for:

-Lab Owners and Executives
-Regulatory Consultants
-Revenue Cycle and Billing Leaders
-Medical Directors
-Compliance Professionals